Actualizado 20/09/2007 22:05 CET
- Comunicado -

European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma (y 2)


Web site: http://www.wyeth.com
http://www.TORISEL.com

Media, Natalie de Vane of Wyeth Pharmaceuticals, +1-484-865-5139, or Douglas Petkus of Wyeth, +1-973-660-5218; Investors, Justin Victoria of Wyeth, +1-973-660-5340